Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Teriflunomide for the treatment of multiple sclerosis.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
ALCAM - Novel multiple sclerosis locus interfering with HLA-DRB1*1501.
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
Drug expenditure of high-cost patients and their characteristics in Finland.
Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study.
Multiple sclerosis and family planning.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.
[Spinal segmental myoclonus in multiple sclerosis (case report).]
Fumaric acid esters in psoriasis and multiple sclerosis.
The use of telemedicine in patients with multiple sclerosis.
Acid-sensing ion channels in pathological conditions.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Revisiting the management of fatigue in multiple sclerosis in the context of rehabilitation: a narrative review of current evidence.
Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go.
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
A prospective cohort study of vitamin D in optic neuritis recovery.
Pages
« first
‹ previous
…
347
348
349
350
351
352
353
354
355
…
next ›
last »